A non-drug device by Neuralieve has been found effective in treating migraine headache in clinical studies.

Modest weight loss and increased physical activity can prevent or delay diabetes in high risk adults, according to a study.

Cabazitaxel, an investigational compound from Sanofi-Aventis, has been found to improve survival rates in prostate cancer patients.

VPRIV (velaglucerase alfa for injection), a human cell line derived enzyme replacement therapy developed by Shire Plc, has been approved for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients in US.